Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ashley

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Epigenetics|April 26, 2012
A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemiaNicholas C Wong, David Ashley, Zac Chatterton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumorClinton F Stewart, Lisa C Iacono, Murali Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumorMaryam Fouladi, Murali Chintagumpala, Fred H Laningham, et al.
Research Square|April 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastomaAnjali Barnwal, Weixuan Yan, Sarah Cook, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendationsMichael Jefford, Nicole Kinnane, Paula Howell, et al.
Neuro-Oncology|September 18, 2008
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNETMurali Chintagumpala, Tim Hassall, Shawna Palmer, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Cancer Medicine|November 27, 2019
Outcomes of a randomized controlled trial assessing a smartphone Application to reduce unmet needs among people diagnosed with CancEr (ACE)Patricia M Livingston, Leila Heckel, Liliana Orellana, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Epigenetics|April 26, 2012
A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemiaNicholas C Wong, David Ashley, Zac Chatterton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumorClinton F Stewart, Lisa C Iacono, Murali Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumorMaryam Fouladi, Murali Chintagumpala, Fred H Laningham, et al.
Research Square|April 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastomaAnjali Barnwal, Weixuan Yan, Sarah Cook, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendationsMichael Jefford, Nicole Kinnane, Paula Howell, et al.
Neuro-Oncology|September 18, 2008
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNETMurali Chintagumpala, Tim Hassall, Shawna Palmer, et al.
Journal of Neuro-Oncology|March 6, 2013
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour studyDarren Hargrave, Birgit Geoerger, Didier Frappaz, et al.
Journal of Personalized Medicine|November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the ClinicJohn P Parisot, Heather Thorne, Andrew Fellowes, et al.
Cancer Medicine|November 27, 2019
Outcomes of a randomized controlled trial assessing a smartphone Application to reduce unmet needs among people diagnosed with CancEr (ACE)Patricia M Livingston, Leila Heckel, Liliana Orellana, et al.
Pageof 7